• Ultra-low PSA Response (<0.02 ng/mL) with Darolutamide Plus ADT in ARANOTE Correlates with Greatly Improved Clinical Outcomes Interactive Poster Session: IP26-07; April 29, 9:30-11:30 a.m. PDT ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

Metformin, which is mainly used to control diabetes, could help prevent an aggressive form of blood cancer, a new study ...

Radiotherapy remains a fundamental treatment for prostate cancer, and recent developments in precision medicine and ...

This article examines the legal implications of AI in healthcare, focusing on liability issues and the need for clear accountability in medical AI applications.

In a Maple Grove industrial strip mall unequipped with the beanbag chairs common to Silicon Valley startups, Francis Medical ...

A breakthrough in research at the University of Missouri involving prostate cancer treatment has resulted in thousands of people receiving life-saving care.

BALTIMORE, April 15, 2025 (GLOBE NEWSWIRE) -- The Urology Care Foundation, the world’s leading nonprofit urological health foundation and the official foundation of the American Urological Association ...

Graham Dean is convinced he would not be here today to enjoy his retirement if he hadn't received an invitation through the post one day for a prostate cancer screening check.

Telix Pharmaceuticals Limited today announces that its prostate cancer PET[1] imaging agent Illuccix® (kit for the preparation of gallium-68 gozetotide injection) has been granted marketing ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® ...